ESC

This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.  

 

CANTOS Study Shows Reducing Inflammation Cuts Cardiovascular Disease, Lung Cancer Risk
News | ESC | September 12, 2017
September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by...
COMPASS Trial Shows Rivaroxaban With Aspirin Improves Stable Cardiovascular Disease
Feature | Antiplatelet and Anticoagulation Therapies | September 12, 2017
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with...
Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study.

Giving oxygen to patients suffering a heart attack is not beneficial, according to the DETO2X-AMI study presented at ESC 2017.

Feature | ESC | September 07, 2017
September 7, 2017 — Oxygen therapy does not improve survival in patients with heart attack symptoms, according to late-...
PURE study may cause revision of fat intake guidelines for cardiology.
Feature | ESC | September 07, 2017
September 7, 2017 — Researchers at the European Society of Cardiology (ESC) Congress called for a reconsideration of...
Biotronik's Orsiro Drug-Eluting Stent Outperforms Xience in BIOFLOW-V Trial
News | Stents Drug Eluting | September 01, 2017
September 1, 2017 — Biotronik recently announced data from the BIOFLOW-V randomized trial comparing Orsiro and Xience...
SPYRAL HTN-OFF MED Study Results Show Efficacy, Safety of Renal Denervation
News | Renal Denervation | August 31, 2017
August 31, 2017 — Medtronic plc announced its intent to move forward with a new renal denervation pivotal trial...
MobiusHD Device Shows Promise in Treatment of Resistant Hypertension
News | Hypertension | August 30, 2017
August 30, 2017 — Vascular Dynamics Inc. announced interim results of the company’s first-in-human trial of its...
Real-World Analysis Compares Safety, Effectiveness of Apixaban Versus Warfarin
News | Antiplatelet and Anticoagulation Therapies | August 28, 2017
August 28, 2017 — Bristol-Myers Squibb Company and Pfizer Inc. announced results from an analysis of real-world data...
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking...